Maximilian Mastall

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma.

A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma.

Journal: Neuro-oncology advances

Published: March 17, 2026

Spinal high-grade astrocytoma with piloid features presenting with progressive encephalopathy, hypoglycorrhachia, hydrocephalus, and leptomeningeal dissemination.

Spinal high-grade astrocytoma with piloid features presenting with progressive encephalopathy, hypoglycorrhachia, hydrocephalus, and leptomeningeal dissemination.

Journal: Journal of neuropathology and experimental neurology

Published: March 04, 2026

Potent antitumor activity through dual targeting of PD-L1 and TGF-β pathways in the glioma tumor microenvironment.

Potent antitumor activity through dual targeting of PD-L1 and TGF-β pathways in the glioma tumor microenvironment.

Journal: Journal for immunotherapy of cancer

Published: January 13, 2026

Case Report: Absent F-Waves in a Case of Spinal Ischemia - A Potential Source of Diagnostic Error.

Case Report: Absent F-Waves in a Case of Spinal Ischemia - A Potential Source of Diagnostic Error.

Journal: Case reports in neurology

Published: November 07, 2025

Targeted next-generation sequencing-based sequencing of cell-free DNA in cerebrospinal fluid uncovers cancer-specific mutations in patients with brain cancer using a widely available panel.

Targeted next-generation sequencing-based sequencing of cell-free DNA in cerebrospinal fluid uncovers cancer-specific mutations in patients with brain cancer using a widely available panel.

Journal: Neuro-oncology advances

Published: October 20, 2025

CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines.

CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines.

Journal: Cell reports. Medicine

Published: March 07, 2024

A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.

A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.

Journal: BMC cancer

Published: December 09, 2023

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.

Journal: Neuro-oncology

Published: June 19, 2023

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.

Journal: Neuro-oncology advances

Published: April 28, 2023

Survival of brain tumour patients with epilepsy.

Survival of brain tumour patients with epilepsy.

Journal: Brain : a journal of neurology

Published: September 28, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026